A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Clinical trial NCT07023614 · RECRUITING
Trial details
- NCT number
- NCT07023614
- Sponsor
- Imbria Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-06
- Primary completion
- 2026-12-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.